Update: 18.03.2025
Last week: 10 week 2024 (03.02.2025 - 09.03.2025)
Last full month: February 2025
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | |||||||||
| WoW | 9 662 | 2.3% | 13.0% | 0.9 | 20 924 335 | 4.1% | 9.6% | 0.8 | -4.8% |
| MoM | 37 047 | 9.5% | 12.5% | -0.4 | 80 317 567 | 15.8% | 9.4% | 0 | 13.1% |
| YTD | 85 006 | 27.6% | 12.7% | 1.6 | 179 811 303 | 20.0% | 9.4% | -0.2 | 11.1% |
| MAT | 439 808 | 23.6% | 12.6% | 3.1 | 869 103 993 | 21.7% | 9.3% | 1.2 | -6.6% |
| BRAINMAX | |||||||||
| WoW | 3 085 | 21.6% | 100.0% | 0 | 10 123 914 | 19.6% | 100.0% | 0 | 21.6% |
| MoM | 9 443 | 11.3% | 100.0% | 0 | 32 675 026 | 8.0% | 100.0% | 0 | 11.3% |
| YTD | 22 242 | 131.1% | 100.0% | 0 | 77 197 851 | 122.1% | 100.0% | 0 | 131.1% |
| MAT | 95 282 | 87.1% | 100.0% | 0 | 329 159 622 | 85.2% | 100.0% | 0 | 87.1% |
| GOLDLINE PLUS | |||||||||
| WoW | 16 930 | 1.7% | 47.3% | 2.2 | 54 490 135 | 1.3% | 38.5% | 2.2 | -3.0% |
| MoM | 65 902 | 0.9% | 45.0% | -0.4 | 214 432 366 | 1.4% | 36.5% | -1.2 | 1.8% |
| YTD | 155 902 | -2.3% | 45.4% | 1.7 | 505 462 935 | -1.8% | 37.2% | 1.1 | -5.9% |
| MAT | 825 397 | -6.0% | 45.8% | 0.4 | 2 593 767 305 | -5.8% | 37.4% | -2 | -6.9% |
| MIGRENIUM | |||||||||
| WoW | 9 045 | 3.7% | 0.4% | 0 | 3 172 195 | 3.3% | 0.5% | 0 | 0.7% |
| MoM | 35 529 | 7.2% | 0.4% | 0 | 12 281 102 | 6.2% | 0.5% | 0 | 0.2% |
| YTD | 82 201 | -31.7% | 0.4% | -0.2 | 28 590 636 | -14.4% | 0.5% | -0.1 | 2.8% |
| MAT | 529 708 | -17.6% | 0.5% | -0.1 | 176 851 317 | 31.3% | 0.6% | 0.1 | 0.4% |
| MODELAX-N | |||||||||
| WoW | 28 836 | -12.6% | 19.2% | -1.7 | 15 184 693 | -11.9% | 13.9% | -1.2 | -5.0% |
| MoM | 138 451 | 5.0% | 22.4% | 1.3 | 71 486 517 | 5.4% | 15.9% | 1.1 | -0.9% |
| YTD | 315 722 | 4.3% | 21.4% | -1 | 163 027 515 | 33.0% | 15.2% | 1.4 | 9.1% |
| MAT | 1 476 654 | 14.9% | 21.5% | 1.9 | 699 748 549 | 56.9% | 14.5% | 3.3 | 5.0% |
| REDUXIN | |||||||||
| WoW | 11 336 | -6.5% | 31.7% | -1.2 | 61 948 685 | -8.0% | 43.7% | -1.7 | -3.0% |
| MoM | 47 539 | 4.1% | 32.5% | 0.7 | 264 568 793 | 8.3% | 45.0% | 1.5 | 1.8% |
| YTD | 110 097 | -9.6% | 32.1% | -1.3 | 601 115 511 | -8.6% | 44.2% | -1.9 | -5.9% |
| MAT | 583 733 | -7.4% | 32.4% | -0.2 | 3 107 027 769 | 3.7% | 44.8% | 2 | -6.9% |
| REDUXIN FORTE | |||||||||
| WoW | 3 521 | -8.7% | 9.8% | -0.6 | 15 656 513 | -9.5% | 11.1% | -0.6 | -3.0% |
| MoM | 15 088 | 7.4% | 10.3% | 0.5 | 67 355 303 | 6.8% | 11.5% | 0.2 | 1.8% |
| YTD | 34 484 | 7.4% | 10.0% | 1.2 | 154 393 114 | 8.2% | 11.4% | 1.3 | -5.9% |
| MAT | 169 730 | 0.2% | 9.4% | 0.7 | 733 414 253 | 6.2% | 10.6% | 0.7 | -6.9% |
| SALVISAR | |||||||||
| WoW | 12 759 | -12.0% | 1.8% | -0.2 | 6 315 627 | -10.9% | 1.7% | -0.1 | -3.8% |
| MoM | 64 379 | 17.6% | 2.2% | 0.4 | 30 950 520 | 19.7% | 2.0% | 0.4 | -2.1% |
| YTD | 139 343 | 65.8% | 2.0% | 0.8 | 66 647 118 | 116.4% | 1.8% | 0.9 | -3.5% |
| MAT | 627 077 | 32.2% | 1.6% | 0.5 | 276 785 738 | 73.3% | 1.5% | 0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 85 006 | 27.6% | 12.7% | 1.6 | 179 811 303 | 20.0% | 9.4% | -0.2 | 11.1% |
| BRAINMAX | 22 242 | 131.1% | 100.0% | 0 | 77 197 851 | 122.1% | 100.0% | 0 | 131.1% |
| GOLDLINE PLUS | 155 902 | -2.3% | 45.4% | 1.7 | 505 462 935 | -1.8% | 37.2% | 1.1 | -5.9% |
| MIGRENIUM | 82 201 | -31.7% | 0.4% | -0.2 | 28 590 636 | -14.4% | 0.5% | -0.1 | 2.8% |
| MODELAX-N | 315 722 | 4.3% | 21.4% | -1 | 163 027 515 | 33.0% | 15.2% | 1.4 | 9.1% |
| REDUXIN CAPS | 110 097 | -9.6% | 32.1% | -1.3 | 601 115 511 | -8.6% | 44.2% | -1.9 | -5.9% |
| REDUXIN FORTE | 34 484 | 7.4% | 10.0% | 1.2 | 154 393 114 | 8.2% | 11.4% | 1.3 | -5.9% |
| SALVISAR | 139 343 | 65.8% | 2.0% | 0.8 | 66 647 118 | 116.4% | 1.8% | 0.9 | -3.5% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 439 808 | 23.6% | 12.6% | 3.1 | 869 103 993 | 21.7% | 9.3% | 1.2 | -6.6% |
| BRAINMAX | 95 282 | 87.1% | 100.0% | 0 | 329 159 622 | 85.2% | 100.0% | 0 | 87.1% |
| GOLDLINE PLUS | 825 397 | -6.0% | 45.8% | 0.4 | 2 593 767 305 | -5.8% | 37.4% | -2 | -6.9% |
| MIGRENIUM | 529 708 | -17.6% | 0.5% | -0.1 | 176 851 317 | 31.3% | 0.6% | 0.1 | 0.4% |
| MODELAX-N | 1 476 654 | 14.9% | 21.5% | 1.9 | 699 748 549 | 56.9% | 14.5% | 3.3 | 5.0% |
| REDUXIN CAPS | 583 733 | -7.4% | 32.4% | -0.2 | 3 107 027 769 | 3.7% | 44.8% | 2 | -6.9% |
| REDUXIN FORTE | 169 730 | 0.2% | 9.4% | 0.7 | 733 414 253 | 6.2% | 10.6% | 0.7 | -6.9% |
| SALVISAR | 627 077 | 32.2% | 1.6% | 0.5 | 276 785 738 | 73.3% | 1.5% | 0.5 | -6.3% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 9 662 | 2.3% | 13.0% | 0.9 | 20 924 335 | 4.1% | 9.6% | 0.8 | -4.8% |
| BRAINMAX | 3 085 | 21.6% | 100.0% | 0 | 10 123 914 | 19.6% | 100.0% | 0 | 21.6% |
| GOLDLINE PLUS | 16 930 | 1.7% | 47.3% | 2.2 | 54 490 135 | 1.3% | 38.5% | 2.2 | -3.0% |
| MIGRENIUM | 9 045 | 3.7% | 0.4% | 0 | 3 172 195 | 3.3% | 0.5% | 0 | 0.7% |
| MODELAX-N | 28 836 | -12.6% | 19.2% | -1.7 | 15 184 693 | -11.9% | 13.9% | -1.2 | -5.0% |
| REDUXIN CAPS | 11 336 | -6.5% | 31.7% | -1.2 | 61 948 685 | -8.0% | 43.7% | -1.7 | -3.0% |
| REDUXIN FORTE | 3 521 | -8.7% | 9.8% | -0.6 | 15 656 513 | -9.5% | 11.1% | -0.6 | -3.0% |
| SALVISAR | 12 759 | -12.0% | 1.8% | -0.2 | 6 315 627 | -10.9% | 1.7% | -0.1 | -3.8% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| AMBENE BIO | 37 047 | 9.5% | 12.5% | -0.4 | 80 317 567 | 15.8% | 9.4% | 0 | 13.1% |
| BRAINMAX | 9 443 | 11.3% | 100.0% | 0 | 32 675 026 | 8.0% | 100.0% | 0 | 11.3% |
| GOLDLINE PLUS | 65 902 | 0.9% | 45.0% | -0.4 | 214 432 366 | 1.4% | 36.5% | -1.2 | 1.8% |
| MIGRENIUM | 35 529 | 7.2% | 0.4% | 0 | 12 281 102 | 6.2% | 0.5% | 0 | 0.2% |
| MODELAX-N | 138 451 | 5.0% | 22.4% | 1.3 | 71 486 517 | 5.4% | 15.9% | 1.1 | -0.9% |
| REDUXIN CAPS | 47 539 | 4.1% | 32.5% | 0.7 | 264 568 793 | 8.3% | 45.0% | 1.5 | 1.8% |
| REDUXIN FORTE | 15 088 | 7.4% | 10.3% | 0.5 | 67 355 303 | 6.8% | 11.5% | 0.2 | 1.8% |
| SALVISAR | 64 379 | 17.6% | 2.2% | 0.4 | 30 950 520 | 19.7% | 2.0% | 0.4 | -2.1% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "MODELAX-N"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #2"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #4"
## [1] "MODELAX-N SOL RECTAL USE 5 ML #8"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "AMBENE BIO"
## [1] "AMBENE BIO SOL FOR INJ 1 ML #10"
## [1] "AMBENE BIO SOL FOR INJ 2 ML #5"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "MIGRENIUM"
## [1] "MIGRENIUM COATED TABLETS 65 MG+500 MG #20"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "SALVISAR"
## [1] "SALVISAR UNGUENT FOR EXT USE 100 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #1"
## [1] "SALVISAR UNGUENT FOR EXT USE 25 G #2"
## [1] "SALVISAR UNGUENT FOR EXT USE 50 G #1"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN CAPS"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #10"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #30"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #60"
## [1] "REDUXIN CAPS 10 MG+158,5 MG #90"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #10"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #30"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #60"
## [1] "REDUXIN CAPS 15 MG+153,5 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "REDUXIN FORTE"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #30"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #60"
## [1] "REDUXIN FORTE COATED TABLETS 850 MG+15 MG #90"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #30"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #60"
## [1] "REDUXIN FORTE TABS 850 MG + 10 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "GOLDLINE PLUS"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 10 MG+158,5 MG #90"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #10"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #30"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #60"
## [1] "GOLDLINE PLUS CAPS 15 MG+153,5 MG #90"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
## [1] "BRAINMAX"
## [1] "BRAINMAX CAPS 250 MG+250 MG #20"
## [1] "BRAINMAX CAPS 250 MG+250 MG #40"
## [1] "BRAINMAX CAPS 250 MG+250 MG #60"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 2,5 ML #10"
## [1] "BRAINMAX SOL FOR INTRAVEN&INTRAMUSC INJ 100 MG/ML+100 MG/ML 5 ML #10"
[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе “MS of competitors” в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection “MS of competitors” in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs